These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26749538)

  • 21. Clinical significance of anti-beta 2-glycoprotein I antibodies.
    Amengual O; Atsumi T; Khamashta MA; Hughes GR
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():15-7. PubMed ID: 8952753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfatides: targets for anti-phospholipid antibodies.
    Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P
    Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
    Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
    J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid antibody and antiphospholipid antibody syndrome.
    Sugai S
    Curr Opin Rheumatol; 1992 Oct; 4(5):666-71. PubMed ID: 1419500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
    Cabral AR; Cabiedes J; Alarcón-Segovia D
    Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
    Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
    Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic review.
    Meijide H; Sciascia S; Sanna G; Khamashta MA; Bertolaccini ML
    Autoimmun Rev; 2013 Jan; 12(3):421-5. PubMed ID: 22951216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG; Smith SA
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome.
    Bas de Laat H; Derksen RH; de Groot PG
    Clin Immunol; 2004 Aug; 112(2):161-8. PubMed ID: 15240159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid and anti-beta 2 glycoprotein I antibodies in monozygotic twin sisters.
    Cevallos R; Darnige L; Arvieux J; Veyssier P; Gruel Y
    J Rheumatol; 1994 Oct; 21(10):1970-1. PubMed ID: 7837171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
    Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
    Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
    Marai I; Tincani A; Balestrieri G; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The new face of phospholipid antibodies].
    Vaarala O
    Duodecim; 1993; 109(21):1890-2. PubMed ID: 7743943
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of synthetic peptide fragments of beta2-glycoprotein-I on binding antiphospholipid antibodies with cardiolipin].
    Kuznetsova TV; Tishchenko VA; Kobylianskiĭ AG; Pal'keeva ME; Sidorova MV; Bespalova ZhD; Nasonov EL
    Biull Eksp Biol Med; 1999 Jan; 127(1):50-2. PubMed ID: 10190004
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiphospholipid antibodies: lessons from the bench.
    Koike T; Bohgaki M; Amengual O; Atsumi T
    J Autoimmun; 2007; 28(2-3):129-33. PubMed ID: 17383159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis.
    Sherer Y; Gerli R; Vaudo G; Schillaci G; Gilburd B; Giordano A; Bocci EB; Allegrucci R; Marchesi S; Mannarino E; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():299-303. PubMed ID: 16126971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.